PARIS, April 15, 2016 -- CGG will announce its first quarter 2016 results on Tuesday May 3rd, 2016, before the opening of the Paris and New York stock exchanges.
-
The press release and the slide presentation will be made available on our website www.cgg.com at 7:30 am.
- An English language analysts conference call is scheduled the same day at 9:00 am (Paris time) - 8:00 am (London time)
To follow this conference, please access the live webcast:
|
From your computer at: From your mobile phone or tablet: |
www.cgg.com |
A replay of the conference will be made available for a period of 12 months via the webcast on CGG website at: www.cgg.com or via the QR code attached above.
For analysts, please dial 5 to 10 minutes prior to the scheduled start time the following numbers:
|
France call-in UK call-in Access code |
+33(0)1 76 77 22 28 +44(0)20 3427 1915 9714715 |
About CGG
CGG ( www.cgg.com ) is a fully integrated Geoscience company providing leading geological, geophysical and reservoir capabilities to its broad base of customers primarily from the global oil and gas industry. Through its three complementary business divisions of Equipment, Acquisition and Geology, Geophysics & Reservoir (GGR), CGG brings value across all aspects of natural resource exploration and exploitation.
CGG employs over 7,000 people around the world, all with a Passion for Geoscience and working together to deliver the best solutions to its customers.
CGG is listed on the Euronext Paris SA (ISIN: 0000120164) and the New York Stock Exchange (in the form of American Depositary Shares. NYSE: CGG).
Contacts
|
Group Communications Christophe Barnini Tel: + 33 1 64 47 38 11 E-Mail: : [email protected] |
Investor Relations Catherine Leveau Tel: +33 1 64 47 34 89 E-mail: : [email protected] |
Press release pdf version http://hugin.info/142000/R/2003798/739714.pdf
HUG#2003798


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FDA Approves Mitapivat for Anemia in Thalassemia Patients
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 



